LexisNexis Risk Solutions Provides LexID to Retail Pharmacy Operations to Improve Patient Records; Craig Ford Quoted

LexisNexis Risk Solutions has partnered with one of the largest nationwide retail pharmacy chains to provide the LexID unique patient identifier across pharmacy operations to centralize records, reduce costs, and make quality healthcare easier to obtain for the pharmacy customers, the company announced on Thursday.

“We’re excited to help our client seamlessly manage customer identities to provide more efficient and consistent care delivery, further supporting the ability to ensure the right patient receives the right prescription at the right time, while promoting the adoption of a unique patient identifier (UPI),” said Craig Ford, Vice President of Pharmacy Markets for LexisNexis Risk Solutions.

LexisNexis will use its automated linking technology, LexID with Customer Record Key, to analyze and connect records common to a single individual. It will then adopt a set of unique identifiers to every patient record nationally to help healthcare organizations match and de-duplicate records, thus creating one source of truth on each individual patient.

The Customer Record Key identifier will be specific to a customer and will add a layer of privacy, especially important for data on minors. The solution will allow healthcare systems to tackle the challenge of lacking data standardization amid an abundance of patient information.

In addition, the LexisNexis Keep Contact solution to further boost patient engagement efforts by enhancing patient demographic and contact information through an identity referential database. The LexisNexis identity solutions help pharmacies keep patient data clean, updated, and available for easy integrations for a streamlined and accurate identification at the point of care.

“Assigning a LexID to an estimated 200 million records nationwide is a huge step for our partner and for the industry,” added Ford.

About LexisNexis Risk Solutions 

LexisNexis® Risk Solutions harnesses the power of data and advanced analytics to provide insights that help businesses and governmental entities reduce risk and improve decisions to benefit people around the globe. We provide data and technology solutions for a wide range of industries including insurance, financial services, health care and government.

Headquartered in metro Atlanta, Georgia, we have offices throughout the world and are part of RELX (LSE: REL/NYSE: RELX), a global provider of information-based and analytics and decision tools for professional and business customers across industries.

You may also be interested in...

THOR Prototype

Army Invests in AFRL’s New Anti-Drone Directed Energy Weapon; Lt. Gen. Neil Thurgood Quoted

The U.S. Army is working with Air Force Research Laboratory (AFRL) to further develop the latter's directed energy weapon that attacks swarms of enemy drones. The partnership between AFRL and the Army will further build the Tactical High Power Operational Responder or THOR prototype, which can neutralize the electronic components of multiple drones at the same time.